UCB Canada Inc.

Apr 01, 2025

[Pr]RYSTIGGO® Now Approved for Adults with Generalized Myasthenia Gravis (gMG) in Canada

Feb 28, 2025

BIMZELX® (bimekizumab) Negotiations with pCPA Concluded Successfully Following Positive CDA and INESSS Recommendations for Adults with Active Psoriatic Arthritis and Adults with Active Ankylosing Spondylitis

Aug 01, 2024

UCB and University Health Network (UHN) Collaborate to Enhance Axial Spondyloarthritis (axSpA) Care in Canada

Mar 14, 2024

BIMZELX® (bimekizumab) Now Approved for Adults with Active Psoriatic Arthritis and for Adults with Axial Spondyloarthritis